CJC-1295 (with DAC)

What is it?

CJC-1295 with Drug Affinity Complex (DAC) is a modified GHRH analogue designed for extended activity in research settings. Supplied as a lyophilized powder for laboratory protocols investigating sustained GHRH-mediated signaling, pituitary pathway activity, and growth-factor regulation in controlled experimental models. The DAC modification supports longer-duration exposure designs relative to non-DAC analogues. Each batch is verified for identity and purity using HPLC and mass spectrometry. Supplied as: Lyophilized powder Purity: 99%+ (HPLC verified) Storage: Store desiccated at -20°C for long-term. Short-term room temperature exposure (around 1 month) during shipping/handling is generally acceptable if kept sealed, dry, and protected from heat/light. Designation: FOR RESEARCH USE ONLY. Not intended for human or animal consumption.